Argenica Therapeutics Share Price and Company Fundamentals



Price
$0.26
Change
0.260 (5200.005%)
52 week
0.255 - 0.32

Last traded: Last Friday at 6:10 AM

Argenica Therapeutics Limited researches and develops a neuroprotective therapeutic drug in Australia. Its lead product candidate is ARG007, a neuroprotective peptide candidate in pre-clinical trials for use in the protection of brain tissue against damage during a stroke. The company was incorporated in 2019 and is based in Nedlands, Australia.

Key Metrics

PE ratio

-

PB ratio

-

Dividend yield

Beta

-

Market cap

-

Enterprise value

$19.02M

Company profile

Primary activitiesDevelopment and commercialisation of a novel therapeutic
Industry / SectorBiotechnology / Healthcare
Websitehttp://www.argenica.com.au
Mailing address29 The Avenue Suite 2 Nedlands WA 6009 Australia
Phone / Fax61 8 9329 3396 /
Share registryLINK MARKET SERVICES LIMITED

Dividends

Argenica Therapeutics does not pay dividends.

Company Executives

As of Jun 2021, following are the company executives and directors listed on Argenica Therapeutics.

NameTitleAgeTotal Pay

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

0.00%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Argenica Therapeutics is and its enterprise value is 19.02M.

Companies similar to Argenica Therapeutics (AGN)

Argenica Therapeutics (ASX:AGN) Frequently Asked Questions

1. What is Argenica Therapeutics's Stock Symbol?

Argenica Therapeutics trades on ASX under the ticker symbol "AGN".

2. What is Argenica Therapeutics's stock price today?

One share of AGN stock can currently be purchased for approximately $0.26.

3. How can I contact Argenica Therapeutics?

Argenica Therapeutics's mailing address is 29 The Avenue Suite 2 Nedlands WA 6009 Australia. The company can be reached via phone at 61 8 9329 3396.

4. What is Argenica Therapeutics's official website?

The official website of Argenica Therapeutics is http://www.argenica.com.au.

5. Which share registry manages Argenica Therapeutics's stock?

Argenica Therapeutics's stock is managed by LINK MARKET SERVICES LIMITED.